Andrea Perna1, Fabio Mancino1, Vincenzo Campana2, Paolo Satta2, Valentina Marcialis2, Davide Glorioso1, Martina Monterossi3, Luca Proietti1, Vincenzo De Santis4. 1. Department of Geriatrics, Neurosciences and Orthopaedics, Fondazione Policlinico Universitario Agostino Gemelli IRCCS. 2. Department of Orthopaedics, Mater Olbia Hospital. 3. Department of Anaesthesiology, Intensive Care Medicine and Toxicology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS. 4. Department of Orthopaedics and Traumatology, Università Cattolica del Sacro Cuore.
Abstract
Background: Starting in January 2020, the SARS-CoV-2 pandemic caused changes in the nation's health systems. The hospital's reorganization led to a near-total stop of non-urgent, elective surgeries across all specialties, including hip and knee arthroplasty. However, in May 2020, a gradual elective surgery restarting was possible. Considering the risk of COVID-19 infections, the European Knee Associates suggest the need to implement specific protocols for a safe return to orthopaedic elective surgery. Methods: A retrospective analysis regarding all patients who underwent primary knee arthroplasty (TKA) between March 1st and October 1st, 2020 using an institutional database was performed. The study time was divided into 2 periods: Pandemic (from March 2020 to May 2020), Post Pandemic (from June 2020 to October 2020). A specific protocol was designed to safeguard the health of patients and healthcare workers during the SARS-CoV-2 pandemic. Results: A total of 147 patients underwent total knee replacement surgery in the analyzed period. The mean surgical time was 77.6 (+/-18.9). The intraoperative mean blood loss was 54 (+/-28) ml. The mean hospital stay was 3-4 days. Among the treated patients no case of COVID-19 infection was observed. Conclusion: The use of our protocol, developed ad hoc for the management of elective orthopedic patients, allowed the restart of elective orthopedic surgery in a safe and reproducible way with an average increase of 374% on surgical activity between the pandemic and post-pandemic periods without record cases of contagion among the treated patients.
Background: Starting in January 2020, the SARS-CoV-2 pandemic caused changes in the nation's health systems. The hospital's reorganization led to a near-total stop of non-urgent, elective surgeries across all specialties, including hip and knee arthroplasty. However, in May 2020, a gradual elective surgery restarting was possible. Considering the risk of COVID-19 infections, the European Knee Associates suggest the need to implement specific protocols for a safe return to orthopaedic elective surgery. Methods: A retrospective analysis regarding all patients who underwent primary knee arthroplasty (TKA) between March 1st and October 1st, 2020 using an institutional database was performed. The study time was divided into 2 periods: Pandemic (from March 2020 to May 2020), Post Pandemic (from June 2020 to October 2020). A specific protocol was designed to safeguard the health of patients and healthcare workers during the SARS-CoV-2 pandemic. Results: A total of 147 patients underwent total knee replacement surgery in the analyzed period. The mean surgical time was 77.6 (+/-18.9). The intraoperative mean blood loss was 54 (+/-28) ml. The mean hospital stay was 3-4 days. Among the treated patients no case of COVID-19 infection was observed. Conclusion: The use of our protocol, developed ad hoc for the management of elective orthopedic patients, allowed the restart of elective orthopedic surgery in a safe and reproducible way with an average increase of 374% on surgical activity between the pandemic and post-pandemic periods without record cases of contagion among the treated patients.
Entities:
Keywords:
COVID-19; Elective surgery; Orthopaedic surgery; TKA; Total Knee Arthroplasty
Authors: R Vitiello; M B Bocchi; M Gessi; T Greco; L Cianni; F de Maio; V Pesce; G Maccauro; C Perisano Journal: J Biol Regul Homeost Agents Date: 2020 Sep-Oct Impact factor: 1.711
Authors: Marco Passiatore; Rocco De Vitis; Andrea Perna; Marco D'Orio; Vitale Cilli; Giuseppe Taccardo Journal: Eur J Orthop Surg Traumatol Date: 2020-05-13
Authors: Vivek N Prachand; Ross Milner; Peter Angelos; Mitchell C Posner; John J Fung; Nishant Agrawal; Valluvan Jeevanandam; Jeffrey B Matthews Journal: J Am Coll Surg Date: 2020-04-09 Impact factor: 6.113
Authors: Andrea Perna; Marco Passiatore; Antonio Massaro; Alessandro Terrinoni; Luca Bianchi; Vitale Cilli; Marco D'Orio; Luca Proietti; Giuseppe Taccardo; Rocco De Vitis Journal: Int J Dermatol Date: 2021-02-02 Impact factor: 3.204
Authors: Domenico De Mauro; Giuseppe Rovere; Alessandro Smimmo; Cesare Meschini; Fabrizio Mocini; Giulio Maccauro; Francesco Falez; Francesco Liuzza; Antonio Ziranu Journal: Int Orthop Date: 2020-07-15 Impact factor: 3.075